Inventor

CHARI RAVI V J

US99 patents

⚠️ This page may combine multiple inventors who share the name “CHARI RAVI V J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHARI RAVI V J

IMMUNOGEN INC

Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents

Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

Cytotoxic agents comprising new maytansinoids

Prodrugs of CC-1065 analogs

Cytotoxic agents comprising taxanes and their therapeutic use

Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use

Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use

CC-1065 analog synthesis

CC-1065 analog synthesis

Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents

Cytotoxic agents comprising taxanes and their therapeutic use

Cytotoxic agents comprising taxanes and their therapeutic use

Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs

Cyclopropylbenzindole-containing cytotoxic drugs

Cell binding agent conjugates of analogues and derivatives of CC-1065

Cytotoxic agents comprising new maytansinoids

Cytotoxic agents comprising new maytansinoids

Prodrugs of CC-1065 analogs

Prodrugs of CC-1065 analogs

Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

Prodrugs of CC-1065 analogs

Prodrugs of CC-1065 analogs

Cytotoxic agents comprising taxanes and their therapeutic use

Cytotoxic agents comprising taxanes and their therapeutic use

Cytotoxic agents comprising taxanes and their therapeutic use

Prodrugs of CC-1065 analogs

Cytotoxic agents containing novel potent taxanes and their therapeutic use

Process for preparation of maytansinol

CC-1065 analog synthesis

Method for the preparation of maytansinoid esters

Cytotoxic benzodiazepine derivatives

Conjugation methods

Cytotoxic benzodiazepine derivatives

Conjugation methods

Cytotoxic benzodiazepine derivatives

Cross-linkers and their uses

LI WEI

Cytotoxic benzodiazepine derivatives

Benzodiazepine derivatives

Benzodiazepine derivatives

Cytotoxic benzodiazepine derivatives

STEEVES RITA M

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

CHARI RAVI V J

Cross-linkers and their uses

Cytotoxic benzodiazepine derivatives and methods of preparation

KELLOGG BRENDA A

Methods for preparation of antibody-maytansinoid conjugates

GAUZY LAURENCE

Cytotoxic agents comprising new tomaymycin derivatives

AVENTIS PHARMA SA

Cytotoxic agents comprising new taxanes